Shortening Compression Time After Radial Access for Cardiac Catheterisation
Shortening Compression Time of the Access Site After Cardiac Catheterisation Through the Radial Artery
1 other identifier
interventional
173
1 country
1
Brief Summary
To obtain arterial access for a diagnostic cardiac catheterization or percutaneous coronary intervention (PCI) the cardiologist can choose between the femoral artery and the radial artery. In the University Medical Center Groningen the femoral artery is commonly used. After intervention the puncture site is closed with an arteriotomy closure device (ACD). Patients after radial access receive a pressure bandage at the puncture site, usually the Terumo (TR) wrist bandage. The bedrest period for patients with an ACD is 1 hour after diagnostic cardiac catheterization and 2 hours after PCI. After the bedrest period patients are discharged 1 hour after diagnostic procedures or 4 hours after PCI. This to observe potential bleeding complications after the procedure. In patients with radial access, the TR bandage will be removed according to current protocol after 4 hours and additionally 1 hour observation is required. Several cardiologists have the intention to use the radial artery more frequent for cardiac catheterization or PCI. In a meta-analysis radial access is related to a 73% decrease in major bleeding complications compared to femoral access. Also there are no significant differences in MACE. Even so there are no differences in success percentage for cardiac catheterization or PCI and admission time is shorter for radial access (Am Heart J. 2009 Jan;157(1):132- 40). Admission time for diagnostic cardiac catheterization at the short-stay unit is in case of femoral access with an ACD approximately 2 hours. For patients after radial access post procedural admission time is approximately 5 hours. To guarantee patient throughput, uniformity of care and more efficient use of capacity of the short-stay unit, patients after radial access should not have a longer hospital admission time than patients after femoral access. Carrington et al. (J Interv Cardiol. 2009 Dec;22(6):571-5) have shown that it is safe to deflate the TR wrist band faster than four hours. Objective of the study: To describe the differences in safety, patient comfort and admission period after diagnostic cardiac catheterization through radial access, between the current protocol and the protocol of fast desufflation by Carrington et al.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2012
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2013
CompletedFirst Submitted
Initial submission to the registry
December 4, 2014
CompletedFirst Posted
Study publicly available on registry
March 25, 2015
CompletedMarch 25, 2015
March 1, 2015
9 months
December 4, 2014
March 24, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Bleeding
Bleeding at puncture site after deflating pressure in TR band
1 year
Secondary Outcomes (3)
Swelling
1 year
Patient comfort
1 year
Time to discharge, after return on nursing unit
1 year
Study Arms (2)
TR Band accelerated
ACTIVE COMPARATORDiminishing air pressure in the TR Band using accelerated protocol
TR band standard
OTHERDiminishing air pressure in the TR band according to standard care
Interventions
Diminishing the air pressure in the TR Band following standard protocol
Diminishing the air pressure in the TR Band following a faster protocol
Eligibility Criteria
You may qualify if:
- Diagnostic coronary angiogram
- Radial access
- French sheath
You may not qualify if:
- Use of oral anticoagulants
- Percutaneous coronary intervention
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Medical Centre Groningen
Groningen, Provincie Groningen, 9713GZ, Netherlands
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Pim van der Harst, MD PhD
University Medical Center Groningen
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MANP
Study Record Dates
First Submitted
December 4, 2014
First Posted
March 25, 2015
Study Start
October 1, 2012
Primary Completion
July 1, 2013
Study Completion
August 1, 2013
Last Updated
March 25, 2015
Record last verified: 2015-03